SpinTech continues to extend the boundaries of MRI and recently earned FDA clearance for STAGE, a rapid, quantitative multi-contrast imaging software that integrates seamlessly into existing clinical workflows. STAGE includes the world’s first FDA cleared QSM output and can be used across a wide range of neurodegenerative disorders such as stroke, Multiple Sclerosis, Parkinson’s, traumatic brain injury, dementia, and tumor imaging. In addition, SpinTech offers automated CMB and Parkinson’s Reports that run on top of STAGE data to aid clinicians in detecting microbleeds and quantifying neuromelanin content, respectively.

Medical Devices

SpinTech MRI

Karen Holzberger

Mark Haacke

Jeff Eardley

James Backstrom

John Ciliberto

Paul Kokeny

Kiarash Ghassaban

Rana El Hachem

Miller Fawaz

Rachel Martis-Laze

The Leadership Team at SpinTech MRI is responsible for driving the company's strategic vision and operational excellence. Comprising the President & CEO, Chief Science Officer, and Chief Revenue Officer, the team focuses on advancing innovative MRI technologies, securing market opportunities, and fostering partnerships to ensure the successful integration of STAGE into clinical practice for improved patient outcomes.

Leadership Team

Product Management Team

Leadership Team

About

Team members

Other teams at SpinTech MRI

Product Management Team